In the past decade it became evident that, like in leukemia, also in most solid cancers, a subpopulation of tumour cells termed cancer stem cells (CSCs) has high tumor-initiating capacity and is the source of metastasis and treatment relapse. Notably, it has been demonstrated that the embryonic epithelial– mesenchymal transition (EMT)-program can be activated in cancer cells, which not only induces an aberrant motility triggering dissemination and metastasis, but also confers stemness properties resulting in a migrating CSC-phenotype.
The program is activated by EMT-inducing transcription factors including members of the Snail-, Twist- and ZEB families5. The EMT-activator ZEB1 turned out to be particularly potent. ZEB1 is associated with aggressive behaviour, metastasis, treatment resistance and poor prognosis in different tumor types, including breast, pancreatic and lung cancer.
Mechanistically, ZEB1 is a transcriptional repressor of epithelial genes, for example, for E-cadherin and cell polarity factors, thereby stimulating an undifferentiated and highly motile phenotype. This property of ZEB1 is considered important for metastasis as shown in many model systems. By repressing the expression of the stemness-inhibiting microRNAs miR-200 and miR-203, ZEB1 can also confer stemness properties, thereby linking motility and stemness towards a migrating cancer stem cell phenotype. Moreover ZEB1, likely through its stemness-promoting effect, can confer survival and therapy resistance, as shown for many different cancer types, such as pancreatic, breast and lung cancer.
Owing to these pleiotropic effects, ZEB1 is considered the central factor for high cancer cell plasticity as a motor towards aggressive, metastatic and therapy-resistant cancer types. However, the strong effects of ZEB1 cannot be solely explained by the ascribed functions as a transcriptional repressor.
In this study, by analysing ZEB1-dependent gene expression patterns, authors demonstrate mechanistic links explaining the extraordinary potency of ZEB1 in driving tumor progression. They describe a direct interaction between ZEB1 and the Hippo pathway effector YAP, shifting ZEB1 from a repressor to a transcriptional activator and thereby linking two pathways with very similar cancerpromoting effects.
Notably, ZEB1 directly binds to YAP, but not to the paralogue factor TAZ. Functional cooperation of ZEB1 and YAP stimulates the transcriptional activation of a ‘common ZEB1/YAP target gene set’.
This gene set is a predictor of poor survival, therapy resistance and increased metastatic risk in hormone receptor-negative breast cancer, indicating the clinical relevance of these findings.
Latest News
Metabolic rewiring promotes…
By newseditor
Posted 18 Apr
A drug to prevent flu-induc…
By newseditor
Posted 18 Apr
New origin of deep brain waves
By newseditor
Posted 17 Apr
Starving cells hijack prote…
By newseditor
Posted 17 Apr
Miniature battery-free epid…
By newseditor
Posted 17 Apr
Other Top Stories
Autosomal dominant Alzheimer's disease and mechanisms of disease pr…
Read more
Genetic and biochemical determinants of brain calcification
Read more
The same protein controls brain size and infertility
Read more
Age-related cognitive decline tied to immune-system molecule
Read more
Mechanism of microglial self-renewal in the brain
Read more
Protocols
MemPrep, a new technology f…
By newseditor
Posted 08 Apr
A tangible method to assess…
By newseditor
Posted 08 Apr
Stem cell-derived vessels-o…
By newseditor
Posted 06 Apr
Single-cell biclustering fo…
By newseditor
Posted 01 Apr
Modular dual-color BiAD sen…
By newseditor
Posted 31 Mar
Publications
How does the microbiota con…
By newseditor
Posted 18 Apr
The integrated stress respo…
By newseditor
Posted 18 Apr
The immunobiology of herpes…
By newseditor
Posted 17 Apr
Circulating microbiome DNA…
By newseditor
Posted 17 Apr
Spindle oscillations in com…
By newseditor
Posted 17 Apr
Presentations
Hydrogels in Drug Delivery
By newseditor
Posted 12 Apr
Lipids
By newseditor
Posted 31 Dec
Cell biology of carbohydrat…
By newseditor
Posted 29 Nov
RNA interference (RNAi)
By newseditor
Posted 23 Oct
RNA structure and functions
By newseditor
Posted 19 Oct
Posters
A chemical biology/modular…
By newseditor
Posted 22 Aug
Single-molecule covalent ma…
By newseditor
Posted 04 Jul
ASCO-2020-HEALTH SERVICES R…
By newseditor
Posted 23 Mar
ASCO-2020-HEAD AND NECK CANCER
By newseditor
Posted 23 Mar
ASCO-2020-GENITOURINARY CAN…
By newseditor
Posted 23 Mar